HD-OPM Archive
Topics › PCSK9, ezetimibe & newer drugs

Ezetimibe lowers LDL-C about 18-20% alone and a further 21-30% on top of a statin

Gokhan Can · Sep 24, 2025 · ♥ 16 reactions · 19 comments · original Facebook post
PCSK9, ezetimibe & newer drugsLDL, ApoB & lipid panel
AI summary & key facts

A quick reference on ezetimibe: it blocks cholesterol absorption in the small intestine and is most useful added to a statin. It also modestly lowers apoB and triglycerides and slightly raises HDL.

LDL Reduction from Ezetimibe

Ezetimibe, when used alone (monotherapy), reduces LDL-C by roughly 15-25%, with studies showing an average reduction of about 18-20%. The primary effectiveness of ezetimibe is in combination with statins, where it can provide an additional 21-30% reduction in LDL-C, leading to greater overall cholesterol reduction.

Ezetimibe Mechanism

Ezetimibe Monotherapy

Ezetimibe with Statins

(Source: Google AI Overviews, which I spot checked)

#ezetimibe#statins#cholesterol#triglycerides#apob
← newer: Cocoa extract supplement lowered hsCRP in older adults, repoolder: After acute coronary syndrome, lower LDL sooner is better, d →